Mark, Laszlo <br/><br/>
The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient.  [electronic resource] 

 -  Current medical research and opinion  Oct 2011 
 - 1959-60; author reply 1961 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2011.606806  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--therapeutic use<br/>Azetidines--therapeutic use<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypercholesterolemia--drug therapy